Kamel Khalili, Ph.D., Thomas Malcolm, Ph.D., Rob Simmons, David Rowe
Company Description
Excision BioTherapeutics Inc. is a life science company focused on the development and commercialization of advanced gene editing therapeutics for the treatment and eradication of life-threatening disease caused by neurotropic viruses.